Start |  Archive |  Services |  About Us |  Contact

Search News

Adolescent Migraine - Zomig Nasal Spray Demonstrates Relief in a Clinical Trial

New clinical trial data presented today at the 47th American Headache Society (AHS) Annual Scientific meeting showed that AstraZeneca's ZOMIG (zolmitriptan) Nasal Spray 5 mg achieved a 58... click link for more info.

Continue to Adolescent Migraine - Zomig Nasal Spray Demonstrates Relief in a Clinical Trial on Medical News Today.

Your health is news!

Medical buzz is a member of the HarWester Network.